$5.66
-0.0800 (-1.39%)
At Close: Jun 22, 2026
Strength Seen in LENSAR, Inc. (LNSR): Can Its 5.3% Jump Turn into More Strength?
12:08pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
LENSAR, Inc. (LNSR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th
Strength Seen in LENSAR, Inc. (LNSR): Can Its 5.3% Jump Turn into More Strength?
09:47am, Wednesday, 20'th Apr 2022
LENSAR, Inc. (LNSR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th
LENSAR, Inc. (LNSR) Moves 13.5% Higher: Will This Strength Last?
11:17am, Monday, 21'st Mar 2022 Zacks Investment Research
LENSAR, Inc. (LNSR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
LENSAR, Inc. (LNSR) Moves 13.5% Higher: Will This Strength Last?
09:02am, Monday, 21'st Mar 2022
LENSAR, Inc. (LNSR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
LENSAR, Inc. (LNSR) Reports Q4 Loss, Tops Revenue Estimates
01:15pm, Thursday, 03'rd Mar 2022 Zacks Investment Research
LENSAR, Inc. (LNSR) delivered earnings and revenue surprises of 31.67% and 31.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
LENSAR, Inc. (LNSR) Reports Q4 Loss, Tops Revenue Estimates
10:46am, Thursday, 03'rd Mar 2022
LENSAR, Inc. (LNSR) delivered earnings and revenue surprises of 31.67% and 31.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Repro Med Systems, Inc. (KRMD) Reports Q4 Loss, Tops Revenue Estimates
10:25pm, Wednesday, 02'nd Mar 2022 Zacks Investment Research
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 5.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the sto
Asensus Surgical (ASXC) Reports Q4 Loss, Tops Revenue Estimates
12:15am, Tuesday, 01'st Mar 2022 Zacks Investment Research
Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 7.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Apollo Endosurgery, Inc. (APEN) Reports Q4 Loss, Tops Revenue Estimates
10:55pm, Tuesday, 22'nd Feb 2022 Zacks Investment Research
Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -35% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc
LENSAR Inc Shares Approach 52-Week Low - Market Mover
02:09am, Tuesday, 11'th Jan 2022 Kwhen Finance
LENSAR Inc (LNSR) shares closed today at 1.9% above its 52 week low of $5.82, giving the company a market cap of $66M. The stock is currently up 0.7% year-to-date, down 13.9% over the past 12 months, and down 33.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 78.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -119.4% The company's stock price performance over the past 12 months lags the peer average by 59.9%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference
01:00pm, Tuesday, 04'th Jan 2022 Kwhen FinanceLENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference
08:00am, Tuesday, 04'th Jan 2022
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR Inc Shares Close in on 52-Week Low - Market Mover
02:14am, Thursday, 23'rd Dec 2021 Kwhen Finance
LENSAR Inc (LNSR) shares closed today at 1.4% above its 52 week low of $5.82, giving the company a market cap of $65M. The stock is currently down 17.1% year-to-date, down 16.9% over the past 12 months, and down 33.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 337.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -739.4% The company's stock price performance over the past 12 months lags the peer average by -266.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q3 2021 Results - Earnings Call Transcript
11:57am, Monday, 08'th Nov 2021
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q3 2021 Results - Earnings Call Transcript
LENSAR, Inc. (LNSR) Reports Q3 Loss, Tops Revenue Estimates
10:01am, Monday, 08'th Nov 2021
LENSAR, Inc. (LNSR) delivered earnings and revenue surprises of -10.17% and 7.84%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Sign In
Buy LNSR